trending Market Intelligence /marketintelligence/en/news-insights/trending/9kuoovlezcswfff9qlhtqw2 content esgSubNav
In This List

Update: Geisinger CEO refutes report he will run joint healthcare venture

Blog

Using ESG Analysis to Support a Sustainable Future

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Podcast

Street Talk Episode 87

Blog

A New Dawn for European Bank M&A Top 5 Trends


Update: Geisinger CEO refutes report he will run joint healthcare venture

David Feinberg, CEO of Geisinger Health System, told CNBC on June 7 that he is staying in his current role, shortly after the news outlet reported that he was the top pick to run the joint healthcare venture between Amazon.com Inc., Berkshire Hathaway Inc. and JPMorgan Chase & Co.

CNBC had cited people close to the selection process who said Feinberg was in active discussions about the job after topping two other final candidates but had not yet accepted an offer.

However, Feinberg told CNBC through a spokesperson that he was "100% committed to Geisinger" and still looking forward to opportunities ahead with the Pennsylvania-based health system. He became Geisinger's CEO in 2015 and has been an adviser to Amazon, Berkshire Hathaway and JPMorgan since their joint venture was announced in January.

In an interview with CNBC earlier the same day, Berkshire Hathaway Chairman, President and CEO Warren Buffett and JPMorgan Chairman and CEO Jamie Dimon confirmed that they had chosen a CEO for the venture and expected to make an announcement within two weeks.

The selection process reportedly called for each of the top 10 candidates to write a white paper about their recommended fixes for the healthcare system, from which the top three choices were determined and sent through final rounds of interviews. The other candidates were not identified by CNBC.

The technology-focused entity in the works aims to cut the costs of healthcare for U.S. employees and families of the three companies.